AstraZeneca's FluMist Home, a nasal flu vaccine available for at-home use, aims to improve vaccination rates among children, especially those afraid of needles. Experts discuss its effectiveness and accessibility.
A new study reveals a worrying decline in MMR vaccination rates among US children, with measles cases spiking. Experts warn of a potential epidemic as misinformation fuels vaccine hesitancy.
A new COVID subvariant has been detected in California, raising concerns of a potential summer wave. Changes in vaccine recommendations could limit access for pregnant women and children, experts warn.
